docetaxel anhydrous has been researched along with Nerve Pain in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 5 (62.50) | 2.80 |
Authors | Studies |
---|---|
Coffeen, U; Velasco-González, R | 1 |
Matta, C; Mensah-Nyagan, AG; Meyer, L; Taleb, O | 1 |
Ataizi, ZS; Ertilav, K; Nazıroğlu, M; Yıldızhan, K | 1 |
Bang, SK; Cho, SJ; Choi, KH; Kang, SY; Kim, HW; Kwon, OS; Lee, JS; Ryu, Y; Seo, SY; Yoo, HS | 1 |
Andersen, NT; Bennedsgaard, K; Bennett, DL; Finnerup, NB; Jensen, TS; Tankisi, H; Themistocleous, AC; Ventzel, L | 1 |
Bian, D; Gao, N; Huang, K; Jiang, B; Wang, R; Zhai, Q | 1 |
Beck, SL; Cohen, JA; Lavoie Smith, EM; Pett, MA | 1 |
Andersen, KG; Eckhoff, L; Gärtner, R; Jensen, MB; Kehlet, H; Kroman, N | 1 |
1 review(s) available for docetaxel anhydrous and Nerve Pain
Article | Year |
---|---|
Neurophysiopathological Aspects of Paclitaxel-induced Peripheral Neuropathy.
Topics: Antineoplastic Agents; Docetaxel; Humans; Microtubules; Neuralgia; Oxidative Stress; Paclitaxel | 2022 |
1 trial(s) available for docetaxel anhydrous and Nerve Pain
Article | Year |
---|---|
The validity of neuropathy and neuropathic pain measures in patients with cancer receiving taxanes and platinums.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carboplatin; Cisplatin; Comorbidity; Docetaxel; Female; Humans; Male; Middle Aged; Neoplasms; Neuralgia; Nursing Assessment; Oncology Nursing; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Pain Measurement; Reproducibility of Results; Risk Factors; Taxoids | 2011 |
6 other study(ies) available for docetaxel anhydrous and Nerve Pain
Article | Year |
---|---|
Behavioral, Electrophysiological, and Histological Characterization of a New Rat Model for Neoadjuvant Chemotherapy-Induced Neuropathic Pain: Therapeutic Potential of Duloxetine and Allopregnanolone Concomitant Treatment.
Topics: Analgesics; Animals; Antineoplastic Agents; Disease Models, Animal; Docetaxel; Duloxetine Hydrochloride; Epirubicin; Female; Neoadjuvant Therapy; Neuralgia; Pain; Pain Measurement; Peripheral Nervous System Diseases; Pregnanolone; Sciatic Nerve | 2020 |
Melatonin and Selenium Suppress Docetaxel-Induced TRPV1 Activation, Neuropathic Pain and Oxidative Neurotoxicity in Mice.
Topics: Animals; Calcium; Docetaxel; Male; Melatonin; Mice; Neuralgia; Oxidative Stress; Selenium; TRPM Cation Channels; TRPV Cation Channels | 2021 |
Treatment of electrical wrist stimulation reduces chemotherapy-induced neuropathy and ultrasound vocalization via modulation of spinal NR2B phosphorylation.
Topics: Animals; Antineoplastic Agents; Docetaxel; Electric Stimulation Therapy; Male; Mice; Mice, Inbred ICR; Neuralgia; Phosphorylation; Receptors, N-Methyl-D-Aspartate; Spinal Cord; Vocalization, Animal | 2020 |
Oxaliplatin- and docetaxel-induced polyneuropathy: clinical and neurophysiological characteristics.
Topics: Aged; Antineoplastic Agents; Diagnostic Techniques, Neurological; Docetaxel; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasms; Neuralgia; Oxaliplatin; Polyneuropathies; Prospective Studies; Quality of Life; Severity of Illness Index | 2020 |
TRPA1 contributed to the neuropathic pain induced by docetaxel treatment.
Topics: Animals; Antineoplastic Agents; Behavior, Animal; Docetaxel; Ganglia, Spinal; Hyperalgesia; Neuralgia; Neurons; Rats; Rats, Wistar; Taxoids; TRPA1 Cation Channel; TRPC Cation Channels | 2017 |
Persistent pain, sensory disturbances and functional impairment after adjuvant chemotherapy for breast cancer: cyclophosphamide, epirubicin and fluorouracil compared with docetaxel + epirubicin and cyclophosphamide.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cross-Sectional Studies; Cyclophosphamide; Denmark; Docetaxel; Epirubicin; Female; Fluorouracil; Foot; Hand; Humans; Lymph Node Excision; Mastectomy; Middle Aged; Multivariate Analysis; Neuralgia; Pain Measurement; Prevalence; Prospective Studies; Radiotherapy; Risk Factors; Sensation Disorders; Severity of Illness Index; Surveys and Questionnaires; Taxoids | 2012 |